BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
BRCA1
,
Metabolism of xenobiotics
,
Diabetes mellitus
,
Embryo
,
Autoimmunity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cho cells
Summary
General Info
Curated Studies
Most Correlated Studies
Diffuse large B cell lymphoma SU-DHL-6, SU-DHL-4 and Farage cells treated with BCL6 inhibitor FX1
T-cell lymphoma CUTLL1 cells with SF3B1 shRNA knockdown
T-cell lymphoma CUTLL1 cells treated with splicing inhibitor E7107
Acute myeloid leukemia HL-60 & MOLM-13 cells treated decitabine & hypomethylating agent NTX-301
Diffuse large B cell lymphomas from brains of primary CNS lymphoma patients
Explore Curated Studies Results
Literature
Most Relevant Literature
In silico design of context-responsive mammalian promoters with user-defined functionality.
Fluorescent protein Dendra2 as a ratiometric genetically encoded pH-sensor.
COL11A1 is overexpressed in gastric cancer tissues and regulates proliferation, migration and invasi…
Cytotoxicity and genotoxicity of silver nanoparticles of different sizes in CHO-K1 and CHO-XRS5 cell…
COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine…
Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell)
Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells)
Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)
Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ